Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC. | Chief Development Officer | Restricted Stock Unit | 77K | $382K | $4.96 | Jan 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZVRA | ZEVRA THERAPEUTICS, INC. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Chief Development Officer |
ZVRA | KEMPHARM, INC | Jan 9, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Chief Product Dev. Officer |
ZVRA | KEMPHARM, INC | Jan 6, 2023 | 0 | $0 | 3 | Jan 10, 2023 | Chief Product Dev. Officer |